"Duration of Preoperative Clear Fluids Fasting in Patients Undergoing Liver Transplant"

NCT ID: NCT07288281

Last Updated: 2026-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-01

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this prospective observational study is to report the duration of preoperative clear fluids fasting in patients undergoing liver transplant. It will also learn about the relationship between the duration of preoperative clear fluids fasting and changes in hemodynamic variables and metabolic profile at various anesthesia and transplant phases. The main questions it aims to answer are:

* How long liver recipient fast from clear fluids before liver transplant?
* Is there any relationship between the duration of preoperative clear fluids fasting and changes in blood pressure and hear rate after the induction of anesthesia?
* Is there any relationship between the duration of preoperative clear fluids fasting and blood glucose concentration, blood lactate concentration and acid base balance during anesthesia for liver transplant?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clear fluids include water, certain juices without pulp (like apple or grape), clear sodas, tea or coffee without milk or cream, clear broth, sports drinks, gelatin, and popsicles without fruit pulp or yogurt.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preoperative Clear Fluid Fasting Liver Transplant Recipient

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

liver recipient

liver transplant recipient undergoing liver transplantation in University Clinical Center of Medical University of Warsaw

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients scheduled for elective liver transplant

Exclusion Criteria

* patients unable to give detailed answer on clear fluid fasting due to severe hepatic encephalopathy or cognitive impairment
* lack of written informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Warsaw

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Clinical Centre of Medical University of Warsaw

Warsaw, Warszawa, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paula Dudek, Medical Doctor

Role: CONTACT

+49225992001

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paula Dudek, medical doctor

Role: primary

+48225992001

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KB/67/2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.